To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06343805
Title A Phase 1 Study of AJ1-11095 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ajax Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stanford Cancer Institute NOT_YET_RECRUITING Palo Alto California 94304 United States Details
Moffitt Cancer Cancer Center RECRUITING Tampa Florida 33612 United States Details
University of Kansas Medical Center RECRUITING Kansas City Kansas 66160 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute RECRUITING Boston Massachusetts 02115 United States Details
Washington University School of Medicine RECRUITING Saint Louis Missouri 63110 United States Details
David H. Koch Center for Cancer Care at Memorial Sloan Kettering NOT_YET_RECRUITING New York New York 10021 United States Details
Icahn School of Medicine at Mount Sinai RECRUITING New York New York 10029 United States Details
Levine Cancer Institute RECRUITING Charlotte North Carolina 28204 United States Details
University of Cincinnati RECRUITING Cincinnati Ohio 45221 United States Details
The Ohio State University Comprehensive Cancer Center RECRUITING Columbus Ohio 43210 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field